Home - Products - Others - Other Targets - 8-Fluoro-1345-tetrahydro-6H-azepino[543-cd]indol-6-one

8-Fluoro-1345-tetrahydro-6H-azepino[543-cd]indol-6-one

CAS No. 1408282-26-7

8-Fluoro-1345-tetrahydro-6H-azepino[543-cd]indol-6-one( —— )

Catalog No. M19779 CAS No. 1408282-26-7

8-Fluoro-1345-tetrahydro-6H-azepino[543-cd]indol-6-one

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 48 In Stock
10MG 68 In Stock
25MG 115 In Stock
50MG 173 In Stock
100MG 258 In Stock
200MG 388 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    8-Fluoro-1345-tetrahydro-6H-azepino[543-cd]indol-6-one
  • Note
    Research use only, not for human use.
  • Brief Description
    8-Fluoro-1345-tetrahydro-6H-azepino[543-cd]indol-6-one
  • Description
    8-Fluoro-1345-tetrahydro-6H-azepino[543-cd]indol-6-one
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1408282-26-7
  • Formula Weight
    204.2
  • Molecular Formula
    C11H9FN2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    Fc1cc2C(=O)NCCc3c[nH]c(c1)c23
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • SMIFH2

    SMIFH2 is formin homology 2 (FH2) domains inhibitor.

  • Etifoxine hydrochlor...

    Etifoxine is an anxiolytic and anticonvulsant drug.?Unlike benzodiazepines, etifoxine appears to produce its anxiolytic effects by binding to β2 and β3 subunits of the GABAA receptor complex, and so is acting at a different target site to benzodiazepines, although the physiological effect that is produced is similar to that of benzodiazepines.

  • Azido-PEG2-azide

    Azido-PEG2-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.